dc.contributor.author | Mauri, D. | en |
dc.contributor.author | Valachis, A. | en |
dc.contributor.author | Polyzos, N. P. | en |
dc.contributor.author | Cortinovis, I. | en |
dc.contributor.author | Karampoiki, V. | en |
dc.contributor.author | Loukidou, E. | en |
dc.contributor.author | Alevizaki, P. | en |
dc.contributor.author | Kamposioras, K. | en |
dc.contributor.author | Kouris, G. | en |
dc.contributor.author | Alexandropoulou, P. | en |
dc.contributor.author | Tsali, L. | en |
dc.contributor.author | Panou, C. | en |
dc.contributor.author | Stamatelopoulos, A. | en |
dc.contributor.author | Lakiotis, V. | en |
dc.contributor.author | Spiliopoulou, A. | en |
dc.contributor.author | Terzoudi, A. | en |
dc.contributor.author | Ioakimidou, A. | en |
dc.contributor.author | Karathanasi, I. | en |
dc.contributor.author | Bristianou, M. | en |
dc.contributor.author | Casazza, G. | en |
dc.contributor.author | Pavlidis, Nicholas | en |
dc.creator | Mauri, D. | en |
dc.creator | Valachis, A. | en |
dc.creator | Polyzos, N. P. | en |
dc.creator | Cortinovis, I. | en |
dc.creator | Karampoiki, V. | en |
dc.creator | Loukidou, E. | en |
dc.creator | Alevizaki, P. | en |
dc.creator | Kamposioras, K. | en |
dc.creator | Kouris, G. | en |
dc.creator | Alexandropoulou, P. | en |
dc.creator | Tsali, L. | en |
dc.creator | Panou, C. | en |
dc.creator | Stamatelopoulos, A. | en |
dc.creator | Lakiotis, V. | en |
dc.creator | Spiliopoulou, A. | en |
dc.creator | Terzoudi, A. | en |
dc.creator | Ioakimidou, A. | en |
dc.creator | Karathanasi, I. | en |
dc.creator | Bristianou, M. | en |
dc.creator | Casazza, G. | en |
dc.creator | Pavlidis, Nicholas | en |
dc.date.accessioned | 2018-06-22T09:53:59Z | |
dc.date.available | 2018-06-22T09:53:59Z | |
dc.date.issued | 2009 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/42133 | |
dc.description.abstract | Purpose: To estimate cancer screening coverage among a large sample of Greek individuals. Methods: 7012 adults from 30 Hellenic areas were surveyed. Tests included: faecal occult blood test, sigmoidoscopy, chest X-ray, urine test, testicular examination, trans-rectal ultrasound, full blood count, skin examination, digital rectal examination, PSA, Pap test, mammography, clinical breast examination (CBE), self breast examination and breast ultrasound. Results: Eighty-eight percent of males and 93% of females declared being interested in cancer screening; 37.8% of men and 37.9% of women had had a medical consultation for screening purpose in the previous 2 years. Less than 2% reported having received screening for colorectal cancer or skin malignancies. Screening for cervical cancer, mammography and CBE was reported by 39.6%, 22.8% and 27.9% of females respectively. Twenty percent of males reported screening for prostate cancer. Conclusion: The actual opportunistic screening approach presents important deficiencies with displaced priorities in test performance and a low proportion of individuals undergoing recommended tests. © Feseo 2009. | en |
dc.language.iso | eng | en |
dc.source | Clinical and Translational Oncology | en |
dc.subject | Greece | en |
dc.subject | Education | en |
dc.subject | Article | en |
dc.subject | Human | en |
dc.subject | Neoplasms | en |
dc.subject | Humans | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Breast neoplasms | en |
dc.subject | Cancer screening | en |
dc.subject | Controlled study | en |
dc.subject | Female | en |
dc.subject | Mammography | en |
dc.subject | Papanicolaou test | en |
dc.subject | Patient participation | en |
dc.subject | Clinical trial | en |
dc.subject | Multicenter study | en |
dc.subject | Colorectal cancer | en |
dc.subject | Neoplasm | en |
dc.subject | Uterine cervix cancer | en |
dc.subject | Male | en |
dc.subject | Melanoma | en |
dc.subject | Blood cell count | en |
dc.subject | Body mass | en |
dc.subject | Sigmoidoscopy | en |
dc.subject | Prostate cancer | en |
dc.subject | Social status | en |
dc.subject | Cancer | en |
dc.subject | Thorax radiography | en |
dc.subject | Colonoscopy | en |
dc.subject | Middle aged | en |
dc.subject | Cervix | en |
dc.subject | Uterine cervical neoplasms | en |
dc.subject | Physical examination | en |
dc.subject | Urinalysis | en |
dc.subject | Occult blood | en |
dc.subject | Attitude to health | en |
dc.subject | Echomammography | en |
dc.subject | Statistics | en |
dc.subject | Breast | en |
dc.subject | Skin cancer | en |
dc.subject | Breast tumor | en |
dc.subject | Screening | en |
dc.subject | Prostatic neoplasms | en |
dc.subject | Breast examination | en |
dc.subject | Colon | en |
dc.subject | Consultation | en |
dc.subject | Digital rectal examination | en |
dc.subject | Health care planning | en |
dc.subject | Health priorities | en |
dc.subject | Male genital system examination | en |
dc.subject | Mass screening | en |
dc.subject | Medical research | en |
dc.subject | Prevention | en |
dc.subject | Preventive medicine | en |
dc.subject | Prostate | en |
dc.subject | Prostate tumor | en |
dc.subject | Rectum | en |
dc.subject | Skin | en |
dc.subject | Transrectal ultrasonography | en |
dc.subject | Uterine cervix tumor | en |
dc.subject | Utilization review | en |
dc.title | Screening practice and misplaced priorities | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1007/s12094-009-0345-7 | |
dc.description.volume | 11 | |
dc.description.issue | 4 | |
dc.description.startingpage | 228 | |
dc.description.endingpage | 236 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |